Global Health Solutions

Global Health Solutions, operating as Turn Therapeutics, is a clinical-stage biotechnology company specializing in advanced wound care, dermatology, and anti-infective therapies. The company's core technology, the PermaFusion™ delivery system, enables the stable suspension of active pharmaceutical ingredients in oil-based carriers to provide potent antimicrobial and anti-inflammatory effects without tissue irritation. Its lead candidate, GX-03 (Hexagen), is being developed for moderate-to-severe atopic dermatitis and onychomycosis, building on a history of over 200,000 human applications and multiple FDA clearances for wound management. The company recently transitioned to a public listing on the Nasdaq under the symbol TTRX following a successful direct listing in late 2025. Turn Therapeutics aims to provide non-steroidal, easy-to-use topical alternatives to existing injectable biologics in the multi-billion dollar dermatology market.